Dr. Albert Do, MD, MPH

Dr. Do practices at Yale New Haven Psychiatric Hospital (York St) in New Haven, Connecticut.

Dr. Do's NPI, 1942575154, was assigned on March 21, 2012. Dr. Do graduated from Boston University School Of Medicine in 2012. Dr. Do holds California license A185832.

Dr. Do's primary practice is Yale New Haven Psychiatric Hospital (York St), at 20 York Street, New Haven, CT 06510. The practice phone is (203) 688-5900.

Dr. Do's primary practice is Yale New Haven Psychiatric Hospital (York St) in New Haven, Connecticut. Dr. Do is also affiliated with UC Davis Medical Center. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Do to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Do practices, 2 sites in all. Vendor and product names are available with a free account.

Hepatology is Dr. Do's primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dr. Do is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Do's licenses on file in 4 states: California, Florida, Connecticut and Rhode Island.

Dmand AI lists acid reflux, cirrhosis, colonoscopy and fatty liver among the conditions Dr. Do treats.

CMS data shows 122 Medicare services from Dr. Do across 5 procedure codes in 2024, for 84 Medicare patients. Medicare paid $7,082 for them.

CMS counts 84 Medicare patients who saw Dr. Do in 2024. The largest group is 65 to 74, with 39 patients. 73% of them have high cholesterol, and 68% have high blood pressure. 43% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Do's median patient age at 57, with 50% women.

In 2024, Dr. Do wrote 109 Medicare Part D claims for 67 patients. 62% of them were for generic drugs. CMS names the drug for 30 of them, across 2 drugs with 11 or more claims each, at $377 in total drug cost. In 2023, CMS named 62 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Do for performance year 2024, reported as part of a group. Dr. Do accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Do as offering telehealth. CMS counts 15 procedures of colonoscopy by Dr. Do, more than 44% of the clinicians it reports for that procedure.

Dmand AI links 30 papers to Dr. Do, published from 2012 to 2024. 2022 was the busiest year, with 5. The most frequent topics are Non-alcoholic Fatty Liver Disease, Liver Cirrhosis and Biopsy. Dr. Do has published most often in Hepatology. Dr. Do's most frequent co-authors are Ysabel Carina Ilagan-Ying, MD, Ramsey Cheung, MD and Tamar Hamosh Taddei, MD.

CMS Open Payments shows 33 general payments to Dr. Do from 7 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 81% of the total. Madrigal Pharmaceuticals paid the most, $19,091.

Dr. Do graduated from Boston University School Of Medicine in 2012.

Dr. Do is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.